Upper Respiratory Tract Infections Introduction

References

• Kennedy DW, Passàli D, et al. Sinus Disease. Health Communications Inc. 1994: 1-48.
   Google Scholar
• Kaliner MA. Sinusitis: bench to bedside. Otolaryngol Head Neck Surg 1997; 100: 510.
   Google Scholar
• Van Cauwenberge P, Watelet JB. Epidemiology of chronic rhinosinusitis. Thorax 2000; 55 (Suppl 2): S20-S21.
   Google Scholar
• Benninger MS, Ferguson BJ, Hadley JA et al. for Chronic Rhinosinusitis Task Force supported by the Sinus and Allergy Health Partnership. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology and pathophysiology. Otolaryngol Head Neck Surg 2003; 129 (Suppl 3): S1-S32.
   Google Scholar
• IMS Italia Servizio Prescrizioni Mediche 1999.
   Google Scholar
• Crotti D, Medori MC, D’Annibale. Evolution of resistances towards macrolides in Streptococcus pyogenes from human throat-swabs for pharyngotonsillitis during ‘90 years. GIMMOC 2001; V, 1: 11-17.
   Google Scholar
• Dolcino M, Tonoli E, Bacca D et al. Valutazione dell’efficacia in vitro di moxifloxacina sui patogeni Gram-positivi e Gram-negativi multiresistenti in confronto con altri fluorochinoloni e attività battericida su S. pyogenes. GIMMOC 1999, III, 3: 227-239.
   Google Scholar
• Felmingham D, Grunenberg RN. A multicentre collaborative study of the antimicrobial susceptibility of communityacquired, lower respiratory tract pathogens 1992-1993: the Alexander Project. J Antimicrob Chemother 1996; 38 Suppl A: 1-57.
   Google Scholar
• Felmingham D, Grunenberg RN. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J Antimicrob Chemother 2000; 45 (2): 191-203.
   Google Scholar
• Marchese A, Mannelli S, Tonoli E. F. et al. Prevalence of antimicrobial resistance in Streptococcus pneumoniae circulating in Italy: results of the Italian Epidemiological Observatory Survey (1997-1999). Microb Drug Resist 2001;7 (3): 277-287.
   Google Scholar
• Marchese A, Montanari M, Nicoletti G et al. Sierotipi di S. pneumoniae circolanti in Italia nel 2000: risultati dello studio epidemiologico per il monitoraggio dello pneumococco resistente (SEMPRE). GIMMOC 2002; Vol. VI n. 3: 139-151.
   Google Scholar
• Schito AM, Schito GC, Debbia E et al. Antibacterial resistance in Streptococcus pneumoniae and Haemophilus influenzae from Italy and Spain: data from the PROTEKT surveillance study, 1999-2000. J Chemother 2003; 15 (3): 226-234.
   Google Scholar
• Ehrlich P. Chemotherapeutics: Scientific principles, methods and results. Lancet. 1913; II: 445-451.
   Google Scholar
• Kozyrskyi AL, Hildes-Ripstein GE, Longstaffe SEA et al. Treatment of acute otitis media with a shortened course of antibiotics. A meta-analysis. JAMA 1998; 279, 21: 1736-1742.
   Google Scholar
• Dagan R, Leibovitz E. Bacterial eradication in the treatment of otitis media.The Lancet Infect Dis, 2002; 2: 593-604.
   Google Scholar
• Block SL, Harrison CJ, Hedrick JA, et al. Penicillin resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J. 1995;14:751-759.
   Google Scholar
• Sinus and Allergy Health Partnership. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngology- Head Neck Surgery 2004, 130, 1: 1-45
   Google Scholar
• Desrosiers M, Frenkiel S, Hamid QA et al. Acute bacterial sinusitis in adults: management in the primary care setting. J Otolaryngol. 2002; 31 Suppl 2: 2S2-14.
   Google Scholar
• Agencie Française de Securité Sanitaire des Produits de Santé. Antibiotherapie par voie generale en pratique courante: sinusite aiguë de l’adulte. Juillet 2001.
   Google Scholar
• Guidelines of German Society for Otorhinolaryngology and Head and Neck Surgery. AWMF 2003, 017/066.
   Google Scholar
• Cooper RJ, Hoffman JR, Bartlett JG et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Intern Med 2001, 134: 509-517.
   Google Scholar
• Centor MR, Witherspoon JM, Dalton HP et al. The diagnosis of strep throat in adults in emergency room. Med Decis Making 1981, 1 (3): 239-246.
   Google Scholar
• Shulman ST, Amren DP, Bisno AL et al. Management in an era of declining rheumatic fever. JAMA 1985; 254: 538-541.
   Google Scholar
• Westlake RM, Graham TP, Edwards KM et al. An outbreak of acute rheumatic fever in Tennessee. Ped Inf Dis 1990; 9 (2): 97-100.
   Google Scholar
• Loeffler AM. Evolution of acute rheumatic fever in the USA between 1982 and 1993. Ped Infect Dis 1996; 15.
   Google Scholar
• Felmingham D, Robbins MJ, Mathias I et al. In vitro activity of moxifloxacin (BAY12-8039), a novel 8-methoxyquinolone, compared with floxacin and other antibiotics. 8th European Congress of Clinical Microbiology and Infectious Diseases, Lausanne, Switzerland 1997.
   Google Scholar
• Garcia-Rodriguez JA, Trujillano I, Fresnadillo MJ et al. In vitro activity of moxifloxacin against respiratory tract pathogens. In “Moxifloxacin in practice” Eds. D. Adam, R. Finch, Maxim Medical Oxford 1999, 2: 37-47.
   Google Scholar
• Blondeau JM. A review of the comparative in vitro activities of 12 antimicrobial agents, with a focus on five new “respiratory quinolones”. JAC 1999, 43, suppl B: 1-11.
   Google Scholar
• Marchese A, Schito GC et al. Osservatorio epidemiologico italiano per il monitoraggio delle resistenze agli antibiotic nei patogeni respiratori comunitari 1997-1999. Significato per la pratica clinica. GIMMOC 2000, 4, 1: 51-58.
   Google Scholar
• Barman Balfour JA, Lamb HM. Moxifloxacin. A review of its clinical potential in the management of communityacquired respiratory tract infections. Drugs 2000, 59, 1: 115-139.
   Google Scholar
• Speciale A, Blandino G, Musumeci R et al. Antibacterial activity of moxifloxacin against pathogens related with respiratory tract infections. 11th European Congress of Clinical Microbiology and Infectious Diseases, Istanbul 2001.
   Google Scholar
• Ghehanno P, Darantière S, Dubreuli C et al. A prospective, multicenter study of moxifloxacin concentration in the sinus mucosa tissue of patients undergoing elective surgery of the sinus. J Antimicrob Chemother 2002; 49: 821-826.
   Google Scholar
• Scheld WM. Maintaining fluoroquinolone class efficacy: review of influencing factors. Emerg Infect Dis 2003; 9(1): 1-9.
   Google Scholar
• Bhavnani SM, Hammel JP, Jones RN, Ambrose PG: Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United States. Diagn Microbiol Infect Dis 2005; 51(1): 31-7.
   Google Scholar
• Niederman MS. Reexamining quiinolone use in the intensive care unit: use them right or lose the fight against resistant bacteria. Crit Care Med 2005; 33(2): 443-4.
   Google Scholar